This strategic combination will provide fertility clinics and IVF laboratories with a comprehensive portfolio of high-quality, innovative products designed to enhance outcomes and increase accessibility to fertility treatments worldwide.
Judith Charpentier, Co-Head of Flagship Fund and Head of Healthcare, Astorg, commented: “This strategic add-on acquisition of a leading portfolio of ART media further strengthens the combined company’s ability to support fertility professionals, clinics, laboratories, and patients by delivering advanced solutions that improve fertility outcomes.
“With the combined business, we stand out as a global category leader driven by innovation and supported by high quality products”, continued Olivier Lieven, Partner, and Tobias Nordblom, Managing Director, Astorg.
Wil Boren, CEO of the combined company added: “We look forward to partnering with the FUJIFILM Irvine Scientific Medical Media Business leadership team and all employees to create a global ART leader together with Hamilton Thorne and Cook Medical’s Reproductive Health business, building on our long-standing commitment to the ART space and strong customer focus.”
Tim Mullane, President, FUJIFILM Irvine Scientific, commented: “This move allows for continued focus on our life sciences businesses within Fujifilm, and for the MBU to thrive under Astorg, who has demonstrated a strong commitment to building capabilities to support the IVF market. We will work closely with Astorg and key stakeholders to ensure a smooth transition of FUJIFILM Irvine Scientific MBU and seamless support for global IVF customers.”
Astorg, FUJIFILM Irvine Scientific, and the management of the combined businesses led by Wil Boren are working actively on integration plans including significant additional investment by Astorg focused on offering fertility clinics and IVF laboratories high quality, innovative and industry leading products.
Healthcare is one of Astorg’s core expertise with over €6.5bn invested in the sector. Astorg invests in global B2B Healthcare leaders, its most recent investments include hg Medical, CordenPharma, OPEN Health, Avania, Cytel, and Clario.
Financial terms for this transaction were not disclosed.
Astorg
Astorg is a leading pan-European private equity firm with over €23 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market leading global companies headquartered in Europe or the US, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Enjoying a distinct entrepreneurial culture, a long-term shareholder perspective and a lean decision-making body, Astorg has valuable industry expertise in healthcare, software, technology, business services and technology-based industrial companies. Headquartered in Luxembourg, Astorg has offices in London, Paris, New York, Frankfurt, and Milan.
For more information about Astorg: www.astorg.com | Follow Astorg on LinkedIn
Hamilton Thorne
Hamilton Thorne is a leading provider of precision instruments, consumables, software, and services including the leading portfolio of ART consumables and equipment from Cook Medical RH including ovum aspiration needles, catheters, and pipettes. The business serves customers in over 115 countries offering fertility clinics and IVF laboratories a comprehensive portfolio of high-quality and innovative products improving the outcomes and accessibility of fertility treatments globally.
For more information about Hamilton Thorne: https://www.hamiltonthorne.ltd/
FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific, Inc. is a global leader in the innovation and manufacture of cell culture solutions for Life Science and Medical markets, providing products and services that assist customers in advancing healthcare initiatives. Working across discovery research, cell and gene therapy, reproductive medicine and cytogenetics, as well as the large-scale production of biotherapeutics and vaccines, the Company is trusted by researchers, manufacturers, and clinicians worldwide.
For over 50 years, FUJIFILM Irvine Scientific’s mission has been to empower all who bring medicines and treatments to life with unmatched quality and responsiveness in its products and custom solutions, providing customers with the vital resources needed to enrich human lives through innovative, accessible therapies. The Company’s facilities adhere to both ISO and FDA regulations, with manufacturing facilities that follow cGMP guidelines in the USA, Japan, and the Netherlands, and a media optimization center in China. All sites prioritize strategies that adhere to the FUJIFILM Sustainability Value Plan 2030 for sustainable growth. FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation. For more information, please visit: www.irvinesci.com.
Further information
Astorg
PR Consultants for Astorg
Prosek Partners (UK)
pro-astorg@prosek.comSteel & Holt (France)
astorg@steeleandholt.comLatest news
Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health, Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment
02 December 2024Astorg Enters into Exclusive Negotiations to Sell its Majority Stake in Anaqua to Nordic Capital
Tech 18 November 2024Astorg Mid-Cap to invest in Redslim in partnership with its Founders and Management Team
07 November 2024